Organization Introduction

History

2023
  • Dec. Announced the 2024 1st phase R&D projects
  • Dec. Nomination of the 2024 4th phase R&D projects (1 project)
  • Oct. MOU signing with the Vaccine Center for Assisting Safety & Technology
  • Sep. Announced the 2023 4th phase R&D projects
  • Sep. Organized the 2023 VITAL-Korea performance sharing conference
  • Sep. Nomination of the 2023 3rd phase R&D projects (2 project)
  • Jul. Nomination of the 2023 2nd phase R&D projects (1 project)
  • Jul. MOU signing with the Public CDMO for Biologics (PCMO, Hwasun province)
  • Jun. Announced the 2023 3rd phase R&D projects
  • May. Co-organized 'Global Vaccine Supply Innovative Technology for Global Cooperation' conference in BIO KOREA 2023
  • Apr. Nomination of the 2023 1st phase R&D projects (9 projects)
2022
  • Dec. Announced the 2023 1st phase R&D projects
  • Oct. Organized the 2022 VITAL-Korea performance sharing conference
  • Oct. MOU signing with the Cell Culture Vaccine Production Center (Andong province)
  • Jul. Nomination of the 2022 2nd phase R&D projects (6 projects)
  • May. Co-organized 'Current Status and Strategy of Self-sufficiency of Vaccine in Korea' conference in BIO KOREA 2022
  • Apr. Nomination of the 2022 1st phase R&D projects (6 projects)
  • Apr. Announced the 2022 2nd phase R&D projects
2021
  • Dec. Announced the 2022 1st phase R&D projects
  • Nov. Organized the 2021 VITAL-Korea performance sharing conference
  • Nov. Co-organized 'Vaccine Development Session' in FIMSA 2021
  • Sep. MOU signing with the Korea Innovative Medicines Consortium (KIMCo)
  • Aug. Nomination of the 2021 2nd phase R&D projects (3 projects)
  • Aug. MOU signing with the Osong Medical Innovation Foundation (KBIO Health) and the Korea Drug Development Fund (KDDF)
  • Jun. Selection & inauguration of the 2021 1st R&D projects (total 1)
  • May. Revised the governance and operational manual of VITAL-Korea
  • May. Announced the 2021 2nd phase R&D projects
  • May. Co-organized the Vaccine Conference in BIO KOREA 2021
  • Apr. MOU signing with the RIGHT Foundation
  • Mar. Announced the 2021 1st phase R&D projects
  • Mar. Nomination of the 2020 2nd phase R&D projects (1 project)
  • Mar. Nomination of the 2020 3rd phase R&D projects (2 projects)
  • Mar. MOU signing with the Government-wide R&D Mar. Fund for Infectious Disease Research (GFID)
  • Jan. Nomination of the 2020 2nd phase R&D projects (14 projects)
2020
  • Dec. Announced the 2020 3rd phase R&D projects
  • Nov. MOU signing with the International Vaccine Institute (IVI)
  • Oct. Nomination of the 1st phase R&D projects (22 projects)
  • Oct. Nomination of the 2020 1st phase R&D projects (22 projects)
  • Jun. Announced 2020 the 1st phase R&D projects
  • Apr. Launched VITAL-Korea (Director General: Baik-Lin Seong)
  • Mar. Established the governance and the operational manual of VITAL-Korea
2019
  • Dec. Public announcement of governmental project VITAL-Korea
  • Mar. Completion of the National planning on “Infectious disease prevention and treatment technology development project”